Concepedia

Boon Khaw Lim

BK

Statistics

Publications

3

Citations

132

H-Index

3

Active since

2022

Affiliations

Centre Hospitalier Universitaire de Toulouse(Current)

European Institute of Oncology

Université Toulouse III - Paul Sabatier

Kindai University

Merck (Germany)

Boon Khaw Lim is an author at Centre Hospitalier Universitaire de Toulouse specializing in radiation oncology, medicine, and oncology.

Top concepts

Publications per year

2022–2024

3

Publications

3

Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial

Yi‐Long Wu, Valentina Guarneri, Pei Jye Voon et al. · The Lancet Oncology · 2024 · 70 citations · Full text

, , +8

LBA52 Tepotinib + osimertinib for EGFRm NSCLC with MET amplification (METamp) after progression on first-line (1L) osimertinib: Initial results from the INSIGHT 2 study

Julien Mazières, T.M. Kim, Boon Khaw Lim et al. · Annals of Oncology · 2022 · 40 citations

, , +5

Tepotinib + osimertinib for <i>EGFR </i>mutant<i> (EGFR</i>m) NSCLC with <i>MET</i> amplification (<i>MET</i>amp) after first-line (1L) osimertinib.

Daniel Shao-Weng Tan, Tae Min Kim, Valentina Guarneri et al. · Journal of Clinical Oncology · 2023 · 22 citations

, , +14

Rows per page

1–3 of 3